Physician profile
David Knox Booth
NPI 1144250689
$4,111.57
in general payments reported to CMS, 2019-2025
38 companies · $646 in 2025
The $646 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,122 · 2020: $307 · 2022: $453 · 2023: $790 · 2024: $793 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,229 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,228.87 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $691.41 | 2019-2025 | Ozempic, Wegovy, Saxenda |
| Abbvie INC. | $612.03 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Glaxosmithkline, LLC. | $328.56 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $282.38 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $272.72 | 2019-2025 | |
| Lilly USA, LLC | $151.85 | 2023-2024 | Mounjaro, Zepbound, Basaglar |
| Merck Sharp & Dohme LLC | $148.76 | 2019-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Exact Sciences Corporation | $129.43 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Welch Allyn | $128.13 | 2020 | |
| Corium, LLC | $120.26 | 2022-2025 | Azstarys |
| Amgen INC. | $116.95 | 2019-2025 | Repatha, Otezla, Repatha |
| Ironshore Pharmaceuticals INC. | $113.14 | 2019-2024 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $111.62 | 2024-2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.08 | 2023-2024 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $92.77 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.